Calviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities

Press/Media: Press / Media

PeriodOct 13 2020

Media coverage

27

Media coverage

  • TitleCalviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities
    Media name/outletTucson.com
    Country/TerritoryUnited States
    Date10/13/20
    PersonsStephen Johnston
  • TitleCalviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities
    Media name/outletBusiness Wire
    Country/TerritoryUnited States
    Date10/13/20
    PersonsStephen Johnston
  • TitleCalviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities
    Media name/outletMorningstar.com
    Country/TerritoryUnited States
    Date10/13/20
    PersonsStephen Johnston
  • TitleCalviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities
    Media name/outletTMC Net
    Country/TerritoryUnited States
    Date10/13/20
    PersonsStephen Johnston
  • TitleCalviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities
    Media name/outletStocksNewsFeed.com
    Country/TerritoryUnited States
    Date10/13/20
    PersonsStephen Johnston
  • TitleCalviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities
    Media name/outletWorldNews.se
    Country/TerritorySweden
    Date10/13/20
    PersonsStephen Johnston
  • TitleCalviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities
    Media name/outletMaryville Daily Times
    Country/TerritoryUnited States
    Date10/13/20
    PersonsStephen Johnston
  • TitleCALVIRI, INC. : Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities
    Media name/outletMarketScreener.com
    Country/TerritoryUnited States
    Date10/13/20
    PersonsStephen Johnston
  • TitleCalviri, Inc. Receives Exclusive Patent License...
    Media name/outletADVFN Deutschland
    Country/TerritoryGermany
    Date10/13/20
    PersonsStephen Johnston
  • TitleCalviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities
    Media name/outletTD Ameritrade
    Country/TerritoryUnited States
    Date10/13/20
    PersonsStephen Johnston
  • TitleCalviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities
    Media name/outletCustomer Zone 360.com
    Country/TerritoryUnited States
    Date10/13/20
    PersonsStephen Johnston
  • TitleCalviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities
    Media name/outletDrug Genius
    Country/TerritoryUnited States
    Date10/13/20
    PersonsStephen Johnston
  • TitleCalviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities
    Media name/outletPICANTE Today
    Country/TerritoryRomania
    Date10/13/20
    PersonsStephen Johnston
  • TitleCalviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities
    Media name/outletDigitalMunition
    Country/TerritoryFrance
    Date10/13/20
    PersonsStephen Johnston
  • Titleadmin wrote a new post, Calviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities
    Media name/outletDigitalMunition
    Country/TerritoryFrance
    Date10/13/20
    PersonsStephen Johnston
  • TitleCalviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities
    Media name/outletJotup
    Country/TerritoryUnited States
    Date10/13/20
    PersonsStephen Johnston
  • TitleCalviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities
    Media name/outletAcrofan
    Date10/13/20
    PersonsStephen Johnston
  • TitleCalviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities
    Media name/outletCIT
    Country/TerritoryUnited States
    Date10/13/20
    PersonsStephen Johnston
  • TitleCalviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities
    Media name/outletIntellasia.net
    Country/TerritoryViet Nam
    Date10/13/20
    PersonsStephen Johnston
  • TitleCalviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities
    Media name/outletOA Online
    Country/TerritoryUnited States
    Date10/13/20
    PersonsStephen Johnston
  • TitleCalviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities
    Media name/outletGalveston County Daily News
    Country/TerritoryUnited States
    Date10/13/20
    PersonsStephen Johnston
  • TitleCalviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities
    Media name/outletElk Valley Times
    Country/TerritoryUnited States
    Date10/13/20
    PersonsStephen Johnston
  • TitleCalviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities
    Media name/outletTullahoma News
    Country/TerritoryUnited States
    Date10/13/20
    PersonsStephen Johnston
  • TitleCalviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities
    Media name/outletManchester Times
    Country/TerritoryUnited States
    Date10/13/20
    PersonsStephen Johnston
  • TitleCalviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities
    Media name/outletYuma Sun
    Country/TerritoryUnited States
    Date10/13/20
    PersonsStephen Johnston
  • TitleCalviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities
    Media name/outletHerald Chronicle
    Country/TerritoryUnited States
    Date10/13/20
    PersonsStephen Johnston
  • TitleCalviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities
    Media name/outletDigital Media Net
    Country/TerritoryUnited States
    Date10/13/20
    PersonsStephen Johnston